Reports - Press Releases

Date	Title	Company
20-Aug-2025	Alomone Labs Integrates Bioz Pro Badges and a Bioz Content Hub to Elevate Research Visibility and Enhance the User Experience	ACCESS Newswire
20-Aug-2025	BioNxt Fast-Tracks U.S. Patent for MS Drug and Secures Broad Platform IP Covering Autoimmune Neurology Pipeline	ACCESS Newswire
20-Aug-2025	Spago Nanomedical Interim Report January-June, 2025	ACCESS Newswire
20-Aug-2025	ANGLE Announces Collaboration with Myriad Genetics	ACCESS Newswire
19-Aug-2025	ADM Tronics Reports First Quarter of Fiscal Year 2026 Results	ACCESS Newswire
19-Aug-2025	Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders	ACCESS Newswire
19-Aug-2025	CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue	ACCESS Newswire
19-Aug-2025	Transparent Co-Management: The Future of Hospital and SNF Rehab	ACCESS Newswire
19-Aug-2025	ASCP Strengthens Voice in Senior Care: Chad Worz Joins PQM PAC/LTC Committee, Along With BOD Members Rob Accetta and Rob Leffler	ACCESS Newswire
19-Aug-2025	Belhaven Biopharma Closes Oversubscribed Series a to Fund the Development of Nasdepi(R) Program Moves Into Late Stage Clinical and Manufacturing Through NDA Approval	ACCESS Newswire
19-Aug-2025	ForCast Orthopedics Announces Expansion of Scientific Advisory Board	ACCESS Newswire
19-Aug-2025	MDCE Readies Major Share Reduction After 2,500% Q2 Revenue Surge	ACCESS Newswire
19-Aug-2025	Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)	ACCESS Newswire
19-Aug-2025	Trulla Helps Baptist Health With Procurement Processes for Autonomous Pharmacy	ACCESS Newswire
19-Aug-2025	IGC Pharma Reports First Quarter Fiscal 2026 Financial Results; Company Accelerates Phase 2 Alzheimer's Trial	ACCESS Newswire
19-Aug-2025	Tenon(R) Medical Announces the Full Market Launch of the Catamaran(R) SE SI Joint Fusion System	ACCESS Newswire
19-Aug-2025	MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage	ACCESS Newswire
19-Aug-2025	Ensysce Biosciences' Geoff Birkett to Chair the Fierce New Product Planning Summit 2025	ACCESS Newswire
19-Aug-2025	Black Book Research Outlines Path for U.S. Healthcare Stakeholders to Support Ukraine's Hospital Recovery	ACCESS Newswire
19-Aug-2025	Zomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent Practices	ACCESS Newswire